Gossamer Bio GOSS
NASDAQ GOSS
$11.28 +0.63 (+5.97%)
At close: Nov 10, 2026 · 4:00 PM EST

Gossamer Bio (GOSS) Total Non-Current Liabilities (2018 - 2026)

Updated

Gossamer Bio (GOSS) recorded Total Non-Current Liabilities of $127.96 million in Q2 2026.

Analysis

Gossamer Bio (GOSS) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Gossamer Bio reported Total Non-Current Liabilities of $295.01 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 102.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 117.60 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 33.91 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 96.04 Bn
10 Gossamer Bio 45.16 Mn -428.23 Mn - 127.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.96 Mn
Dec 31, 2025 295.01 Mn
Dec 31, 2018 358.77 Mn
API Access

Gossamer Bio Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GOSS&period=max&api_key=YOUR_API_KEY